BioSkryb Genomics to Present Novel Research on Tumor Heterogeneity at American Association for Cancer Research (AACR) Annual Meeting 2024
BioSkryb will highlight its new automation-ready ResolveDNA® and ResolveOME™ single-cell core kits, and share new breast cancer research and a spotlight presentation
DURHAM, N.C. – March 28, 2024 -BioSkryb Genomics, a company ushering in the next generation of single-cell technology, will highlight…
March 13, 2024
BioSkryb Launches New Whole Genome and Transcriptome Core Kits to Accelerate Single-Cell Multiomics
New ResolveDNA® and ResolveOME™ single-cell kits generate sequencing-ready libraries in under eight hours
DURHAM, N.C. – March 13, 2024 -BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome a…
January 30, 2024
BioSkryb Genomics to Highlight Power of Next Generation Single-Cell Technology at AGBT 2024
BioSkryb to introduce new products and novel applications of industry-leading portfolio that advance the single-cell multiomics field through simultaneous interrogation of DNA, RNA, and targeted proteins from each cell
DURHAM, N.C. – January 30, 2024 -BioSkryb Genomics, a company transforming singl…
November 28, 2023
BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer
Ram Laxman brings executive leadership experience from 10x Genomics, Illumina, and Pacific Biosciences to expand BioSkryb’s international footprint
DURHAM, N.C. – November 29, 2023 -BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of th…
October 30, 2023
BioSkryb Genomics to Present New Single-Cell Multiomic Data at ASHG 2023
BioSkryb will participate in two CoLab Sessions on single-cell whole genome sequencing and four poster presentations with new pancreatic and breast cancer data
DURHAM, N.C. – October 30, 2023 -BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic vie…
September 13, 2023
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products
DURHAM, N.C. – September 13, 2023 -BioSkryb Genomics, a company transforming single-cell analysis by e…
August 30, 2023
BioSkryb Genomics Partners with Research Instruments Pte Ltd to Bring Industry Leading Single-Cell Technologies to Singapore and Southeast Asia
Strategic distribution agreement with Research Instruments expands access to BioSkryb’s best-in-class single-cell multiomics portfolio throughout Southeast Asia
DURHAM, N.C. – August 30, 2023 -BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic…
August 17, 2023
Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies
U.S. issued patent expands BioSkryb’s IP portfolio to four granted patents in key geographic markets worldwide
DURHAM, N.C. – August 17, 2023 -BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to…
August 2, 2023
BioSkryb Genomics to Bring High-Throughput Automation to Single-Cell Genomics
The product solution combines HP’s new D100 Single Cell Dispenser with BioSkryb’s ResolveDNA® technology to enable the investigation of large single-cell genomics studies with unprecedented coverage and accuracy
DURHAM, N.C. – August 3, 2023 - BioSkryb Genomics, a pioneer in comprehensive single…
July 18, 2023
BIOKÉ and BioSkryb Genomics announce a distribution agreement for the Benelux and Nordic countries
LEIDEN July 18, 2023 - BIOKÉ, a leading distributor of life science technologies throughout Europe, has partnered with BioSkryb Genomics (BioSkryb), a pioneer in comprehensive single-cell multiomic research solutions, to distribute Primary Template-directed Amplification (PTA) technology acr…